Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
360 EUR | -0.28% | +0.14% | +0.14% |
May. 03 | VIRBAC : Virbac remains an attractive animal healthcare play | |
Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated |
Sales 2024 * | 1.38B 1.49B | Sales 2025 * | 1.48B 1.6B | Capitalization | 3.01B 3.26B |
---|---|---|---|---|---|
Net income 2024 * | 139M 150M | Net income 2025 * | 155M 167M | EV / Sales 2024 * | 2.24 x |
Net Debt 2024 * | 73.54M 79.47M | Net cash position 2025 * | 44M 47.55M | EV / Sales 2025 * | 2.01 x |
P/E ratio 2024 * |
21.8
x | P/E ratio 2025 * |
19.7
x | Employees | 5,459 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.45% | Free-Float | 49.58% |
Latest transcript on Virbac
1 day | -0.28% | ||
1 week | +0.14% | ||
Current month | +3.75% | ||
1 month | +0.28% | ||
3 months | +3.75% | ||
6 months | +26.98% | ||
Current year | +0.14% |
Managers | Title | Age | Since |
---|---|---|---|
Sébastien Huron
CEO | Chief Executive Officer | 54 | 05-12-31 |
Habib Ramdani
DFI | Director of Finance/CFO | 48 | 16-01-31 |
Sophie Favini
COO | Chief Operating Officer | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philippe Capron
BRD | Director/Board Member | 65 | 03-12-31 |
Chairman | 59 | 97-12-31 | |
Director/Board Member | 63 | 94-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 1 M€ | -.--% | ||
0.02% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 360 | -0.28% | 2 273 |
24-05-22 | 361 | +0.56% | 2,643 |
24-05-21 | 359 | +2.57% | 4,760 |
24-05-20 | 350 | -1.27% | 2,985 |
24-05-17 | 354.5 | -1.39% | 5,447 |
Real-time Euronext Paris, May 23, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.14% | 3.27B | |
-13.47% | 78.51B | |
+9.97% | 8.37B | |
+23.38% | 3.71B | |
-3.71% | 1.64B | |
+13.01% | 1.64B | |
-21.59% | 1.36B | |
+2.54% | 1.34B | |
-9.96% | 1.22B | |
+2.78% | 1.12B |
- Stock Market
- Equities
- VIRP Stock